BLLN

BillionToOne, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-11

Figures on this page computed 2026-11-08 12:40 UTC

Last close

113.94USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2025, filed 2026-03-11

633.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-11
The filing itself
16.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
The filing itself
2.4%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself
5.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself
0.23Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.04 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.73x

-0.19x

-0.52x

1.00x

1.17x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-06

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-11

Sales1.73x
Its own average over 3 years, 176.5M.
Profit-0.19x
Its own average over 3 years, -38.9M.
Free cash flow-0.52x
Its own average over 3 years, -30.3M.
Debt1.00x
Its own average over 2 years, 109.1M.
Price1.17x
Its own average over 2 years, 97. Market data, 2026-11-06

Free cash flow is furthest from its own average, at -0.52 times.

Sales is 1.73 times its own 3-year average; Profit is -0.19 times its own 3-year average; Free cash flow is -0.52 times its own 3-year average; Debt is 1.00 times its own 2-year average; Price is 1.17 times its own 2-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-11

Sales against its own 3-year average1.73
Source
filed
Statement
income
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Profit against its own 3-year average-0.19
Source
filed
Statement
income
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Free cash flow against its own 3-year average-0.52
Source
filed
Statement
income
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Debt against its own 2-year average1.00
Source
filed
Statement
income
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
The filing itself
Price against its own 2-year average1.17Market data, 2026-11-06
Source
market
Taken on
2026-11-06
Reported in
USD